NORTH CHICAGO, Ill.,
Feb. 16, 2017 /PRNewswire/
-- The board of directors of AbbVie Inc. (NYSE: ABBV) declared
a quarterly cash dividend of $0.64
per share.
The cash dividend is payable May 15,
2017 to stockholders of record at the close of business on
April 13, 2017.
Since the company's inception in 2013, AbbVie has increased its
dividend by 60 percent. AbbVie is a member of the S&P
Dividend Aristocrats Index, which tracks companies that have
annually increased their dividend for at least 25 consecutive
years.
About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed
in 2013 following separation from Abbott Laboratories. The
company's mission is to use its expertise, dedicated people and
unique approach to innovation to develop and market advanced
therapies that address some of the world's most complex and serious
diseases. Together with its wholly-owned subsidiary, Pharmacyclics,
AbbVie employs approximately 30,000 people worldwide and markets
medicines in more than 170 countries. For further information on
the company and its people, portfolio and commitments, please visit
www.abbvie.com. Follow @abbvie on Twitter or view careers on our
Facebook or LinkedIn page.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-300408947.html
SOURCE AbbVie Inc.